2015
DOI: 10.1097/01.ccm.0000474885.18915.b0
|View full text |Cite
|
Sign up to set email alerts
|

1054

Abstract: 30.1 ml/kg vs. OB 17 ml/kg, p<0.01) was lower in the OB group. In both groups, the drip rates were significantly lower in patients who failed versus those who did not. Conclusions: This study questions the efficacy of non-weight vasopressor dosing. Adequately dosing obese patients may result in faster obtainment of goal MAP and decreased use of secondary agents. Randomized trials are needed to validate these results and examine adverse event rates.Learning Objectives: AMP-activated protein kinase (AMPK) is a c… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles